This week, Peter Simons provides an update on the FDA's controversial approval of Alzheimer's drug aducanumab, a new guideline for psychoeducation about ADHD, a study linking poverty rates and youth suicide, and an article providing essential information about antidepressant withdrawal.

• Federal Investigation into FDA Approval of Alzheimer’s Drug
• Guideline for Education about ADHD
• Poverty Rates in US Counties Predict Youth Suicide Risk
• Four Essential Studies on Antidepressant Withdrawal Every Prescriber Must Read